ArticleCureus2026

Cholecalciferol Supplementation and Transplant Outcomes Across Immunosuppressive Regimens in Renal Transplant Recipients Using the United States Food and Drug Administration Adverse Event Reporting System.

Toru Ogura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.